Nicotinamide Mononucleotide (NMN)
What is Nicotinamide Mononucleotide (NMN)?
Nicotinamide mononucleotide (CAS 1094-61-7), abbreviated NMN and also recognized commercially as beta-NMN, is a nucleotide derivative of niacinamide; a direct biosynthetic precursor to NAD+.
Where is Nicotinamide Mononucleotide (NMN) used?
- Nutraceutical and dietary supplement manufacturing: capsules, tablets, and sublingual powders targeting NAD+ replenishment
- Cosmetics: anti-aging serums and moisturizing creams
- Pharmaceutical and biotech research: intermediate in the synthesis of NAD+ analogs
- Life sciences laboratories: reference standard in metabolic pathway studies and biochemical reagent in cell culture and enzymatic assay development
- It supports cellular energy metabolism pathways.
Commercial specifications
- 98%+ purity material suitable for research and supplement applications
- bulk quantities and smaller research-scale packaging
Other Names (Synonyms)
Nicotinamide mononucleotide|Nicotinamide ribonucleoside 5'-phosphate|Nicotinamide D-ribonucleotide|beta-NMN|beta-delta-NMN|b-NMN|b-D-NMN|3-Carbamoyl-1-b-D-ribofuranosylpyridinium hydroxide 5'-phosphate inner salt|3-(aminocarbonyl)-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium, inner salt|NMN